Riverstone Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Sell |
8,194
-2,650
| -24% | -$231K | 0.39% | 27 |
|
|
2025
Q1 | $741K | Sell |
10,844
-5,721
| -35% | -$391K | 0.45% | 26 |
|
|
2024
Q4 | $1.29M | Sell |
16,565
-2,687
| -14% | -$209K | 0.73% | 20 |
|
|
2024
Q3 | $1.29M | Sell |
19,252
-2,566
| -12% | -$172K | 0.75% | 19 |
|
|
2024
Q2 | $2.47M | Sell |
21,818
-23,160
| -51% | -$2.63M | 1.52% | 15 |
|
|
2024
Q1 | $6.24M | Sell |
44,978
-2,260
| -5% | -$313K | 3.72% | 8 |
|
|
2023
Q4 | $5.86M | Sell |
47,238
-3,032
| -6% | -$376K | 3.79% | 9 |
|
|
2023
Q3 | $4.69M | Sell |
50,270
-976
| -2% | -$91.1K | 3.24% | 10 |
|
|
2023
Q2 | $6.59M | Sell |
51,246
-766
| -1% | -$98.4K | 4% | 10 |
|
|
2023
Q1 | $6.04M | Buy |
52,012
+2,098
| +4% | +$244K | 3.86% | 11 |
|
|
2022
Q4 | $5.65M | Sell |
49,914
-718
| -1% | -$81.3K | 3.92% | 11 |
|
|
2022
Q3 | $4.08M | Sell |
50,632
-4,884
| -9% | -$393K | 2.63% | 11 |
|
|
2022
Q2 | $4.14M | Buy |
55,516
+28
| +0.1% | +$2.09K | 2.6% | 12 |
|
|
2022
Q1 | $7.1M | Sell |
55,488
-264
| -0.5% | -$33.8K | 3.64% | 12 |
|
|
2021
Q4 | $7.48M | Buy |
55,752
+1,320
| +2% | +$177K | 3.29% | 12 |
|
|
2021
Q3 | $7.44M | Buy |
54,432
+1,316
| +2% | +$180K | 3.43% | 11 |
|
|
2021
Q2 | $5.67M | Buy |
53,116
+512
| +1% | +$54.7K | 2.68% | 14 |
|
|
2021
Q1 | $4.73M | Buy |
52,604
+3,540
| +7% | +$318K | 2.47% | 14 |
|
|
2020
Q4 | $4.54M | Buy |
49,064
+26,164
| +114% | +$2.42M | 2.52% | 13 |
|
|
2020
Q3 | $2.36M | Buy |
22,900
+4,624
| +25% | +$477K | 1.57% | 17 |
|
|
2020
Q2 | $1.85M | Buy |
+18,276
| New | +$1.85M | 1.38% | 17 |
|